Cargando…

S100A10 protein expression is associated with oxaliplatin sensitivity in human colorectal cancer cells

BACKGROUND: Individual responses to oxaliplatin (L-OHP)-based chemotherapy remain unpredictable. The objective of our study was to find candidate protein markers for tumor sensitivity to L-OHP from intracellular proteins of human colorectal cancer (CRC) cell lines. We performed expression difference...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Sayo, Yamayoshi, Yasuko, Nishimuta, Akito, Tanigawara, Yusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317844/
https://www.ncbi.nlm.nih.gov/pubmed/22206547
http://dx.doi.org/10.1186/1477-5956-9-76
_version_ 1782228634179731456
author Suzuki, Sayo
Yamayoshi, Yasuko
Nishimuta, Akito
Tanigawara, Yusuke
author_facet Suzuki, Sayo
Yamayoshi, Yasuko
Nishimuta, Akito
Tanigawara, Yusuke
author_sort Suzuki, Sayo
collection PubMed
description BACKGROUND: Individual responses to oxaliplatin (L-OHP)-based chemotherapy remain unpredictable. The objective of our study was to find candidate protein markers for tumor sensitivity to L-OHP from intracellular proteins of human colorectal cancer (CRC) cell lines. We performed expression difference mapping (EDM) analysis of whole cell lysates from 11 human CRC cell lines with different sensitivities to L-OHP by using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS), and identified a candidate protein by liquid chromatography/mass spectrometry ion trap time-of-flight (LCMS-IT-TOF). RESULTS: Of the qualified mass peaks obtained by EDM analysis, 41 proteins were differentially expressed in 11 human colorectal cancer cell lines. Among these proteins, the peak intensity of 11.1 kDa protein was strongly correlated with the L-OHP sensitivity (50% inhibitory concentrations) (P < 0.001, R(2 )= 0.80). We identified this protein as Protein S100-A10 (S100A10) by MS/MS ion search using LCMS-IT-TOF. We verified its differential expression and the correlation between S100A10 protein expression levels in drug-untreated CRC cells and their L-OHP sensitivities by Western blot analyses. In addition, S100A10 protein expression levels were not correlated with sensitivity to 5-fluorouracil, suggesting that S100A10 is more specific to L-OHP than to 5-fluorouracil in CRC cells. S100A10 was detected in cell culture supernatant, suggesting secretion out of cells. CONCLUSIONS: By proteomic approaches including SELDI technology, we have demonstrated that intracellular S100A10 protein expression levels in drug-untreated CRC cells differ according to cell lines and are significantly correlated with sensitivity of CRC cells to L-OHP exposure. Our findings provide a new clue to searching predictive markers of the response to L-OHP, suggesting that S100A10 is expected to be one of the candidate protein markers.
format Online
Article
Text
id pubmed-3317844
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33178442012-04-04 S100A10 protein expression is associated with oxaliplatin sensitivity in human colorectal cancer cells Suzuki, Sayo Yamayoshi, Yasuko Nishimuta, Akito Tanigawara, Yusuke Proteome Sci Research BACKGROUND: Individual responses to oxaliplatin (L-OHP)-based chemotherapy remain unpredictable. The objective of our study was to find candidate protein markers for tumor sensitivity to L-OHP from intracellular proteins of human colorectal cancer (CRC) cell lines. We performed expression difference mapping (EDM) analysis of whole cell lysates from 11 human CRC cell lines with different sensitivities to L-OHP by using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS), and identified a candidate protein by liquid chromatography/mass spectrometry ion trap time-of-flight (LCMS-IT-TOF). RESULTS: Of the qualified mass peaks obtained by EDM analysis, 41 proteins were differentially expressed in 11 human colorectal cancer cell lines. Among these proteins, the peak intensity of 11.1 kDa protein was strongly correlated with the L-OHP sensitivity (50% inhibitory concentrations) (P < 0.001, R(2 )= 0.80). We identified this protein as Protein S100-A10 (S100A10) by MS/MS ion search using LCMS-IT-TOF. We verified its differential expression and the correlation between S100A10 protein expression levels in drug-untreated CRC cells and their L-OHP sensitivities by Western blot analyses. In addition, S100A10 protein expression levels were not correlated with sensitivity to 5-fluorouracil, suggesting that S100A10 is more specific to L-OHP than to 5-fluorouracil in CRC cells. S100A10 was detected in cell culture supernatant, suggesting secretion out of cells. CONCLUSIONS: By proteomic approaches including SELDI technology, we have demonstrated that intracellular S100A10 protein expression levels in drug-untreated CRC cells differ according to cell lines and are significantly correlated with sensitivity of CRC cells to L-OHP exposure. Our findings provide a new clue to searching predictive markers of the response to L-OHP, suggesting that S100A10 is expected to be one of the candidate protein markers. BioMed Central 2011-12-30 /pmc/articles/PMC3317844/ /pubmed/22206547 http://dx.doi.org/10.1186/1477-5956-9-76 Text en Copyright ©2011 Suzuki et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Suzuki, Sayo
Yamayoshi, Yasuko
Nishimuta, Akito
Tanigawara, Yusuke
S100A10 protein expression is associated with oxaliplatin sensitivity in human colorectal cancer cells
title S100A10 protein expression is associated with oxaliplatin sensitivity in human colorectal cancer cells
title_full S100A10 protein expression is associated with oxaliplatin sensitivity in human colorectal cancer cells
title_fullStr S100A10 protein expression is associated with oxaliplatin sensitivity in human colorectal cancer cells
title_full_unstemmed S100A10 protein expression is associated with oxaliplatin sensitivity in human colorectal cancer cells
title_short S100A10 protein expression is associated with oxaliplatin sensitivity in human colorectal cancer cells
title_sort s100a10 protein expression is associated with oxaliplatin sensitivity in human colorectal cancer cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317844/
https://www.ncbi.nlm.nih.gov/pubmed/22206547
http://dx.doi.org/10.1186/1477-5956-9-76
work_keys_str_mv AT suzukisayo s100a10proteinexpressionisassociatedwithoxaliplatinsensitivityinhumancolorectalcancercells
AT yamayoshiyasuko s100a10proteinexpressionisassociatedwithoxaliplatinsensitivityinhumancolorectalcancercells
AT nishimutaakito s100a10proteinexpressionisassociatedwithoxaliplatinsensitivityinhumancolorectalcancercells
AT tanigawarayusuke s100a10proteinexpressionisassociatedwithoxaliplatinsensitivityinhumancolorectalcancercells